Results 241 to 250 of about 476,553 (353)
Using a novel zebrafish‐based inflammatory screening strategy, we screened and identified 18β‐glycyrrhetinic acid (18β‐GA) as a promising anti‐inflammatory candidate. We uncover a microglial mTOR–autophagy–NLRP3 axis that constitutes the mechanistic core of 18β‐GA–mediated neuroprotection.
Hua Gan +11 more
wiley +1 more source
Targeting PAK4 promotes Gemcitabine-induced pyroptosis in pancreatic cancer via NLRP1/caspase-3/GSDME axis. [PDF]
Lu T +7 more
europepmc +1 more source
Aspartic vinyl sulfones: Inhibitors of a caspase-3-dependent pathway
Paulo M.C. Glória +8 more
openalex +1 more source
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong +8 more
wiley +1 more source
Therapeutic Exosomes Carrying VEGFA siRNA Inhibit Pathological Corneal Angiogenesis via PI3K-Akt-Caspase-3 Signaling. [PDF]
Hur W +6 more
europepmc +1 more source
Activation of Caspases-3, -6, and -9 during Finasteride Treatment of Benign Prostatic Hyperplasia [PDF]
Aline Bözec +6 more
openalex +1 more source
ABSTRACT Acute liver injury (ALI), driven by diverse insults such as drug toxicity and ischemia‐reperfusion, poses a high mortality risk and lacks targeted therapies. While reactive oxygen species (ROS), neutrophil extracellular traps (NETs), and a coordinated cell death pathway PANoptosis have been implicated, their interplay as a unified pathogenic ...
Xiaopeng Cai +13 more
wiley +1 more source
Super-Sensitive Chemiluminescent Probe for the Detection of Caspase-3 Activity. [PDF]
Tannous R, Zhang C, Shabat D.
europepmc +1 more source
Imuno-expressão de Cox-2, Caspase 3, Ki67 e Survivina em tumor venéreo transmissível canino.
Sandra Bassani Silva +3 more
openalex +1 more source
A mitochondria‐targeted copper depletion nanoplatform (CYN‐CDA@Alb) was developed to selectively disrupt tumor mitochondria copper, which then reprogrammed the tumor immune microenvironment by depressing PD‐L1 and CD47 expression simultaneously. By doing this, CYN‐CDA@Alb reversed radiotherapy‐induced immune tolerance, showing the potential usage of ...
Zaigang Zhou +10 more
wiley +1 more source

